RT Journal Article
SR Electronic
T1 1200 Leveraging the immunocompetent Vk*MYC<sup>hCRBN</sup> model of multiple myeloma to determine and overcome T cell engager antibody resistance mechanisms
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1323
OP A1323
DO 10.1136/jitc-2023-SITC2023.1200
VO 11
IS Suppl 1
A1 Meermeier, Erin W
A1 Stein, Caleb
A1 Sharik, Meaghen
A1 Du, Megan
A1 Shi, Chang-Xin
A1 Zhu, Yuan Xiao
A1 Abayasiriwardana, Keith
A1 Fisher, Timothy
A1 Baaten, Bas
A1 Bezman, Natalie
A1 Bompiani-Myers, Kristin
A1 Leif Bergsagel, P
A1 Chesi, Marta
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1323.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.